Cost-effectiveness analysis of colorectal cancer treatments

被引：24
|
作者：
van den Hout, WB
van den Brink, M
Stiggelbout, AM
van de Velde, CJH
Kievit, J
机构：
[1] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷 / 07期
关键词：
cost-effectiveness analysis; methodology; survey; colorectal cancer;
D O I：
10.1016/S0959-8049(02)00053-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：953 / 963
页数：11
相关论文
共 50 条
  • [31] Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study
    Sophie Whyte
    Susan Harnan
    Cancer Causes & Control, 2014, 25 : 647 - 658
  • [32] Probabilistic Cost-Effectiveness Comparison of Screening Strategies for Colorectal Cancer
    Tafazzoli, Ali
    Roberts, Stephen
    Klein, Robert
    Ness, Reid
    Dittus, Robert
    ACM TRANSACTIONS ON MODELING AND COMPUTER SIMULATION, 2009, 19 (02):
  • [33] Cost-effectiveness of colorectal cancer screening in renal transplant recipients
    Wong, Germaine
    Howard, Kirsten
    Craig, Jonathan C.
    Chapman, Jeremy R.
    TRANSPLANTATION, 2008, 85 (04) : 532 - 541
  • [34] Revisiting the starting age of colorectal cancer screening in Hong Kong: a cost-effectiveness analysis
    Huang, Junjie
    Zhong, Claire Chenwen
    Chan, Victor
    Liu, Xianjing
    Zhong, Chaoying
    Lin, Jianli
    Hang, Junjie
    Yuan, Jinqiu
    Xu, Wanghong
    Withers, Mellissa
    Chan, Andrew T.
    Wong, Martin C. S.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55 : 108 - 108
  • [35] Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market
    Davari, Majid
    Ashrafi, Farzaneh
    Maracy, Mohammadreza
    Aslani, Abolfazl
    Tabatabaei, Mohammadreza
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2015, 6
  • [36] Cost-Effectiveness Analysis of Molecular Screening to Identify Lynch Syndrome in the Patients with Colorectal Cancer
    Azardoost, Hananeh
    Rahimi, Farimah
    Zeinalian, Mehrdad
    Rezayatmand, Reza
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2021, 14 (04)
  • [37] Cost-effectiveness analysis of increasing access to colorectal cancer diagnosis with limited colonoscopy capacities: an example from Thailand
    Wongseree, Peeradon
    Hasgul, Zeynep
    Jalali, Mohammad
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP163 - NP165
  • [38] Cost-effectiveness analysis of neurocognitive-sparing treatments for brain metastases
    Savitz, Samuel T.
    Chen, Ronald C.
    Sher, David J.
    CANCER, 2015, 121 (23) : 4231 - 4239
  • [39] Indirect costs and cost-effectiveness analysis
    Ernst, Richard
    VALUE IN HEALTH, 2006, 9 (04) : 253 - 261
  • [40] Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China
    Peng, Zhi
    Hou, Xingduo
    Huang, Yangmu
    Xie, Tong
    Hua, Xinyang
    BMC CANCER, 2020, 20 (01)
12345